Keyphrases
Urothelial Bladder Cancer
100%
Bladder Cancer
100%
Protein-DNA Complex
100%
Biomarker Discovery
100%
Urinary Biomarkers
100%
Cancer DNA
100%
Nucleic Acids
66%
Protein Biomarkers
66%
Healthcare Professionals
33%
DNA Methylation (DNAm)
33%
Clinical Presentation
33%
High Cost
33%
Molecular Pathogenesis
33%
Disease Diagnosis
33%
Complex Disease
33%
Risk Stratification
33%
Cost Burden
33%
Cystoscopic
33%
PubMed
33%
Molecular Subtypes
33%
Omics Technologies
33%
Long-term Surveillance
33%
RNA Markers
33%
Computational Biology
33%
Gradual Shifts
33%
Detection Test
33%
DNA mutation
33%
Technological Innovation
33%
DNA Markers
33%
Flexible Cystoscopy
33%
Diagnostic Biomarker
33%
Mutation Profiling
33%
Literature Analysis
33%
RNA-directed DNA Methylation (RdDM)
33%
Risk Predicting
33%
Detection Risk
33%
Predicting Response to Therapy
33%
Protein Biomarker Discovery
33%
Medicine and Dentistry
Bladder Cancer
100%
Biological Marker
100%
DNA RNA Hybridization
100%
Deoxyribonucleoprotein
100%
Diagnosis
33%
Nucleic Acid
33%
Diseases
33%
Health Care Cost
16%
Urinary System
16%
Molecular Pathology
16%
Risk Stratification
16%
Cystoscopy
16%
Tamsulosin
16%
DNA Methylation
16%
RNA Methylation
16%
Biochemistry, Genetics and Molecular Biology
RNA
100%
Biomarker Discovery
100%
DNA RNA Hybridization
100%
Nucleic Acid
66%
DNA Methylation
33%
Medline
33%
Tamsulosin
33%
RNA Methylation
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Biological Marker
100%
Nucleic Acid
33%
Diseases
33%
Molecular Pathology
16%
Tamsulosin
16%